Answers are grounded in this paper and cite their sources.
Background Pemphigus is a severe autoimmune bullous disease with a poor prognosis. Pulmonary lesions are life‐threatening but understudied complications whose risk factors and genetic basis remain unclear. Objectives To investigate clinical factors and genetic susceptibility associated with pulmonary lesions in pemphigus patients, and to develop an exploratory model to characterize clinically accessible indicators of pulmonary involvement. Methods We retrospectively included 56 pemphigus patients classified by standardized chest CT review. Clinical variables, PDAI scores, candidate SNPs, and LDSC‐based genetic correlations were analyzed. An exploratory logistic model was internally evaluated using cross‐validation and calibration. Results Pulmonary lesion incidence was significantly higher than in the general population ( p < 0.001). Advanced age ( p = 0.0046) and high‐dose glucocorticoid ( p < 0.0001) were independent risk factors. No significant associations were found for gender, disease duration, PDAI, rituximab, or genetics (all p > 0.05). The model showed excellent performance (AUC = 0.91). Conclusions Pulmonary lesions in pemphigus were associated with advanced age and higher glucocorticoid exposure. These findings highlight the need for greater pulmonary awareness, especially in elderly patients or those receiving higher steroid doses, and may provide preliminary evidence to support clinicians in treatment planning.
No takes yet. Share an insight, caveat, or question.
Ji et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: